These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20030434)

  • 1. Zonisamide in Parkinson's disease: profile report.
    Yang LP; Perry CM
    Drugs Aging; 2010 Jan; 27(1):73-5. PubMed ID: 20030434
    [No Abstract]   [Full Text] [Related]  

  • 2. Zonisamide: in Parkinson's disease.
    Yang LP; Perry CM
    CNS Drugs; 2009 Aug; 23(8):703-11. PubMed ID: 19594199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination Therapy with Zonisamide and Antiparkinson Drugs for Parkinson's Disease: A Meta-Analysis.
    Matsunaga S; Kishi T; Iwata N
    J Alzheimers Dis; 2017; 56(4):1229-1239. PubMed ID: 28157097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zonisamide: a new drug for Parkinson's disease.
    Murata M
    Drugs Today (Barc); 2010 Apr; 46(4):251-8. PubMed ID: 20502722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Actigraphic study of tremor before and after treatment with zonisamide in patients with Parkinson's disease.
    Mochio S; Sengoku R; Kono Y; Morita M; Mitsumura H; Takagi S; Kamiyama T; Oka H
    Parkinsonism Relat Disord; 2012 Aug; 18(7):906-8. PubMed ID: 22546334
    [No Abstract]   [Full Text] [Related]  

  • 6. Zonisamide in patients with essential tremor and Parkinson's disease.
    Bermejo PE
    Mov Disord; 2007 Oct; 22(14):2137-8. PubMed ID: 17853481
    [No Abstract]   [Full Text] [Related]  

  • 7. Zonisamide for the treatment of Parkinson's disease.
    Miwa H
    Expert Rev Neurother; 2007 Sep; 7(9):1077-83. PubMed ID: 17868006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of zonisamide in a case of Parkinson's disease with intractable resting and re-emergent tremor.
    Iijima M; Osawa M; Kobayashi M; Uchiyama S
    Eur J Neurol; 2011 Apr; 18(4):e43-4. PubMed ID: 21159065
    [No Abstract]   [Full Text] [Related]  

  • 9. Zonisamide has beneficial effects on Parkinson's disease patients.
    Murata M; Horiuchi E; Kanazawa I
    Neurosci Res; 2001 Dec; 41(4):397-9. PubMed ID: 11755227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zonisamide in managing impulse control disorders in Parkinson's disease.
    Bermejo PE; Ruiz-Huete C; Anciones B
    J Neurol; 2010 Oct; 257(10):1682-5. PubMed ID: 20509031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zonisamide improves wearing-off in Parkinson's disease: A randomized, double-blind study.
    Murata M; Hasegawa K; Kanazawa I; Fukasaka J; Kochi K; Shimazu R;
    Mov Disord; 2015 Sep; 30(10):1343-50. PubMed ID: 26094993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel therapeutic effects of the anti-convulsant, zonisamide, on Parkinson's disease.
    Murata M
    Curr Pharm Des; 2004; 10(6):687-93. PubMed ID: 14965331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zonisamide: review of its use in epilepsy therapy.
    Zareba G
    Drugs Today (Barc); 2005 Sep; 41(9):589-97. PubMed ID: 16341290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel anti-Parkinsonian agent, zonisamide, attenuates MPTP-induced neurotoxicity in mice.
    Yano R; Yokoyama H; Kuroiwa H; Kato H; Araki T
    J Mol Neurosci; 2009 Sep; 39(1-2):211-9. PubMed ID: 19199078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zonisamide for seizures in Parkinson's disease with dementia.
    Tombini M; Pellegrino G; Di Pino G; Assenza G
    Seizure; 2013 May; 22(4):324-5. PubMed ID: 23403093
    [No Abstract]   [Full Text] [Related]  

  • 16. Preventing effects of a novel anti-parkinsonian agent zonisamide on dopamine quinone formation.
    Asanuma M; Miyazaki I; Diaz-Corrales FJ; Miyoshi K; Ogawa N; Murata M
    Neurosci Res; 2008 Jan; 60(1):106-13. PubMed ID: 18022268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zonisamide improves motor function in Parkinson disease: a randomized, double-blind study.
    Murata M; Hasegawa K; Kanazawa I;
    Neurology; 2007 Jan; 68(1):45-50. PubMed ID: 17200492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zonisamide-induced long-lasting recovery of dopaminergic neurons from MPTP-toxicity.
    Choudhury ME; Moritoyo T; Kubo M; Kyaw WT; Yabe H; Nishikawa N; Nagai M; Matsuda S; Nomoto M
    Brain Res; 2011 Apr; 1384():170-8. PubMed ID: 21320474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The discovery of an antiparkinsonian drug, zonisamide].
    Murata M
    Rinsho Shinkeigaku; 2010 Feb; 50(2):67-73. PubMed ID: 20196486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of zonisamide co-administration with levodopa on global gene expression in the striata of rats with Parkinson's disease.
    Ueda Y; Tokashiki S; Kanemaru A; Kojima T
    Biochem Biophys Res Commun; 2012 Nov; 428(3):401-4. PubMed ID: 23103374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.